4.0 Article

High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease

出版社

INT UNION CRYSTALLOGRAPHY
DOI: 10.1107/S1744309111018367

关键词

-

资金

  1. National Institute of Allergy and Infectious Diseases
  2. National Institutes of Health
  3. Department of Health and Human Services [HHSN272200700057C]

向作者/读者索取更多资源

The establishment of an efficient and reliable protein-purification pipeline is essential for the success of structural genomic projects. The SSGCID Protein Purification Group at the University of Washington (UW-PPG) has established a robust protein-purification pipeline designed to purify 400 proteins per year at a rate of eight purifications per week. The pipeline was implemented using two AKTAexplorer 100s and four AKTAprimes to perform immobilized metal-affinity chromatography (IMAC) and size-exclusion chromatography. Purifications were completed in a period of 5 d and yielded an average of 53 mg highly purified protein. This paper provides a detailed description of the methods used to purify, characterize and store SSGCID proteins. Some of the purified proteins were treated with 3C protease, which was expressed and purified by UW-PPG using a similar protocol, to cleave non-native six-histidine tags. The cleavage was successful in 94% of 214 attempts. Cleaved proteins yielded 2.9% more structures than uncleaved six-histidine-tagged proteins. This 2.9% improvement may seem small, but over the course of the project the structure output from UW-PPG is thus predicted to increase from 260 structures to 318 structures. Therefore, the outlined protocol with 3C cleavage and subtractive IMAC has been shown to be a highly efficient method for the standardized purification of recombinant proteins for structure determination via X-ray crystallography.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba

Logan Tillery, Kayleigh Barrett, Jenna Goldstein, Jared W. Lassner, Bram Osterhout, Nathan L. Tran, Lily Xu, Ryan M. Young, Justin Craig, Ian Chun, David M. Dranow, Jan Abendroth, Silvia L. Delker, Douglas R. Davies, Stephen J. Mayclin, Brandy Calhoun, Madison J. Bolejack, Bart Staker, Sandhya Subramanian, Isabelle Phan, Donald D. Lorimer, Peter J. Myler, Thomas E. Edwards, Dennis E. Kyle, Christopher A. Rice, James C. Morris, James W. Leahy, Roman Manetsch, Lynn K. Barrett, Craig L. Smith, Wesley C. Van Voorhis

Summary: Naegleria fowleri is a pathogenic amoeba that causes primary amebic meningoencephalitis by traveling to the brain via the olfactory nerves, thriving in warm freshwater environments with low drug sensitivity. Efforts have been made to identify potential drug targets through protein production and crystallography, with promising results of pathogen-specific inhibitors.

PLOS ONE (2021)

Article Biochemistry & Molecular Biology

Structural insights into the function of the catalytically active human Taspase1

Nirupa Nagaratnam, Silvia L. Delker, Rebecca Jernigan, Thomas E. Edwards, Janey Snider, Darren Thifault, Dewight Williams, Brent L. Nannenga, Mary Stofega, Lidia Sambucetti, James J. Hsieh, Andrew J. Flint, Petra Fromme, Jose M. Martin-Garcia

Summary: Taspase1 is an Ntn-hydrolase overexpressed in primary human cancers, with its activity closely related to the proliferation, invasion, and metastasis of cancer cells. This study reveals the structure and function of the active site of Taspase1, providing a potential target for the development of anticancer therapeutics.

STRUCTURE (2021)

Article Multidisciplinary Sciences

Structural characterization of a Type B chloramphenicol acetyltransferase from the emerging pathogen Elizabethkingia anophelis NUHP1

Seyed Mohammad Ghafoori, Alyssa M. Robles, Angelika M. Arada, Paniz Shirmast, David M. Dranow, Stephen J. Mayclin, Donald D. Lorimer, Peter J. Myler, Thomas E. Edwards, Misty L. Kuhn, Jade K. Forwood

Summary: Elizabethkingia anophelis is an emerging multidrug resistant pathogen with antibiotic resistance genes including a chloramphenicol acetyltransferase (CAT). The high-resolution crystal structure of CAT protein from E. anophelis NUHP1 strain shows similarity to Type B (CatB) proteins from other bacteria, suggesting its role in chloramphenicol resistance. This research expands the structural and functional understanding of proteins from Flavobacteriaceae pathogens.

SCIENTIFIC REPORTS (2021)

Article Microbiology

Aconitate decarboxylase 1 participates in the control of pulmonary Brucella infection in mice

Aurore Demars, Armelle Vitali, Audrey Comein, Elodie Carlier, Abdulkader Azouz, Stanislas Goriely, Justine Smout, Veronique Flamand, Megane Van Gysel, Johan Wouters, Jan Abendroth, Thomas E. Edwards, Arnaud Machelart, Eik Hoffmann, Priscille Brodin, Xavier De Bolle, Eric Muraille

Summary: Brucellosis is a common bacterial zoonosis worldwide. The Acod1 gene plays a key role in controlling pulmonary Brucella infection in mice. The ACOD1 enzyme converts cis-aconitate to itaconate and may be a potential target for pharmacological interventions in treating early stages of pulmonary Brucella infection.

PLOS PATHOGENS (2021)

Article Biochemistry & Molecular Biology

Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme

Pooja Kesari, Anuradha Deshmukh, Nikhil Pahelkar, Abhishek B. Suryawanshi, Ishan Rathore, Vandana Mishra, John H. Dupuis, Huogen Xiao, Alla Gustchina, Jan Abendroth, Mehdi Labaied, Rickey Y. Yada, Alexander Wlodawer, Thomas E. Edwards, Donald D. Lorimer, Prasenjit Bhaumik

Summary: Plasmodium falciparum plasmepsin X (PfPMX), an essential protein for the survival of the deadliest malaria parasite, has been identified as a potential drug target. The crystal structure of PfPMX zymogen, which contains a novel fold of its prosegment, has been determined for the first time. The study provides insights into the inactivation, maturation, and inhibition of PfPMX, which could aid in the development of potent inhibitors against similar proteases from apicomplexan parasites.

PROTEIN SCIENCE (2022)

Article Biochemical Research Methods

Crystal structures of FolM alternative dihydrofolate reductase 1 from Brucella suis and Brucella canis

Imani Porter, Trinity Neal, Zion Walker, Dylan Hayes, Kayla Fowler, Nyah Billups, Anais Rhoades, Christian Smith, Kaelyn Smith, Bart L. Staker, David M. Dranow, Stephen J. Mayclin, Sandhya Subramanian, Thomas E. Edwards, Peter J. Myler, Oluwatoyin A. Asojo

Summary: Members of the bacterial genus Brucella, which can be used as biological warfare agents, cause brucellosis, a zoonotic disease affecting livestock and wildlife. The structures of FolM alternative dihydrofolate reductases 1 from Brucella suis and Brucella canis were determined and reported in this study. These enzymes show high sequence similarity to each other but low sequence identity with other structurally known homologues. The structures resemble NADPH-dependent short-chain reductases and share their highest tertiary structural similarity with protozoan pteridine reductases.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2022)

Article Biochemical Research Methods

Crystal structure of a hypothetical protein from Giardia lamblia

Dylan K. Beard, Seonna Bristol, Kayla Cosby, Amber Davis, Courtney Manning, Lionel Perry, Lauren Snapp, Arian Toy, Kayla Wheeler, Jeremy Young, Bart Staker, Tracy L. Arakaki, Jan Abendroth, Sandhya Subrahamanian, Thomas E. Edwards, Peter J. Myler, Oluwatoyin A. Asojo

Summary: Giardiasis is the most prevalent diarrheal disease globally, affecting both humans and animals, particularly in developing countries, travelers, and HIV-infected individuals. Treatment involves antibiotics like tinidazole and metronidazole, with ongoing research focusing on characterizing the proteins of Giardia lamblia to develop new therapeutics. This study presents the atomic resolution structure of a 15.6 kDa protein from Giardia lamblia, providing insights into potential targets for drug development.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2022)

Article Biochemical Research Methods

Crystal structure of betaine aldehyde dehydrogenase from Burkholderia pseudomallei

Dylan K. Beard, Sandhya Subramanian, Jan Abendroth, David M. Dranow, Thomas E. Edwards, Peter J. Myler, Oluwatoyin A. Asojo

Summary: This study reports the crystal structures of the potential drug target BADH from B. pseudomallei. Structural comparison revealed similarities to BADH from Pseudomonas aeruginosa, which could facilitate drug-repurposing studies for B. pseudomallei.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2022)

Article Biochemical Research Methods

Crystal structure of an inorganic pyrophosphatase from Chlamydia trachomatis D/UW-3/Cx

Jasmine Maddy, Bart L. Staker, Sandhya Subramanian, Jan Abendroth, Thomas E. Edwards, Peter J. Myler, Kevin Hybiske, Oluwatoyin A. Asojo

Summary: Chlamydia trachomatis is a leading cause of bacterial sexually transmitted infections worldwide and a common infection in the United States. The development of new therapeutics is necessary due to drug resistance and the failure of current treatments to clear persistent infections. The Seattle Structural Genomics Center for Infectious Disease has determined the structures of potential drug targets for C. trachomatis, including the inorganic pyrophosphatase. The crystal structure of the inorganic pyrophosphatase reveals shared features that could aid in the repurposing of inhibitors for new therapeutics.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Molecular mechanism for strengthening E-cadherin adhesion using a monoclonal antibody

Bin Xie, Allison Maker, Andrew Priest, David M. Dranow, Jenny N. Phan, Thomas E. Edwards, Bart L. Staker, Peter J. Myler, Barry M. Gumbiner, Sanjeevi Sivasankar

Summary: The monoclonal antibody 19A11 can interact with Ecad in two distinct modes, one of which enhances the adhesion of Ecad. Adhesion is strengthened by the formation of a salt bridge.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Chemistry, Medicinal

Efficacy and Mode of Action of a Direct Inhibitor of Mycobacterium abscessus InhA

Mattheo Alcaraz, Francoise Roquet-Baneres, Stephen Adonai Leon-Icaza, Jan Abendroth, Yves-Marie Boudehen, Celine Cougoule, Thomas E. Edwards, Laurent Kremer

Summary: There is a significant medical need for effective treatments against Mycobacterium abscessus pulmonary infections, especially in cystic fibrosis (CF) patients. In this study, the antitubercular drug NITD-916 was found to have low minimum inhibitory concentration (MIC) values against M. abscessus in vitro, and it significantly reduced bacterial burden in human macrophages. Furthermore, NITD-916 treatment decreased the number and size of intracellular mycobacterial cords, indicating its potential in treating this difficult-to-treat mycobacterium. The study also confirmed that NITD-916 directly targets InhA(MAB) without activation requirements.

ACS INFECTIOUS DISEASES (2022)

Review Infectious Diseases

New therapeutic strategies for Mycobacterium abscessus pulmonary diseases - untapping the mycolic acid pathway

Mattheo Alcaraz, Thomas E. Edwards, Laurent Kremer

Summary: The treatment options for Mycobacterium abscessus infections are limited. The authors review the potential drug targets in M. abscessus related to the mycolic acid biosynthetic pathway and discuss the activity of inhibitors targeting MmpL3 and InhA. They highlight the potential of NITD-916 as a direct InhA inhibitor for the treatment of multidrug resistant M. abscessus infections.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2023)

Article Biochemical Research Methods

Characterization of a family I inorganic pyrophosphatase from Legionella pneumophila Philadelphia 1

Julia Moorefield, Yagmur Konuk, Jordan O. Norman, Jan Abendroth, Thomas E. Edwards, Donald D. Lorimer, Stephen J. Mayclin, Bart L. Staker, Justin K. Craig, Kayleigh F. Barett, Lynn K. Barrett, Wesley C. Van Voorhis, Peter J. Myler, Krystle J. McLaughlin

Summary: Inorganic pyrophosphatases hydrolyze the byproduct PPi and prevent its accumulation in cells, while providing orthophosphates P-i for biosynthetic pathways. L. pneumophila PPase demonstrates hydrolytic activity with Mg2+ as the preferred metal cofactor for catalysis.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2023)

Article Chemistry, Medicinal

Structure-Kinetic Relationship Studies for the Development of Long Residence Time LpxC Inhibitors

Sneha Basak, Yong Li, Suyuan Tao, Fereidoon Daryaee, Jonathan Merino, Chendi Gu, Silvia L. Delker, Jenny N. Phan, Thomas E. Edwards, Stephen G. Walker, Peter J. Tonge

Summary: UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) is a potential drug target in Gram-negative bacteria, and the residence time of inhibitors on this target is found to be correlated with their post-antibiotic effect. The study also demonstrates that an analogue has a longer residence time and post-antibiotic effect, providing a platform for rational modulation of inhibitor residence time and the development of antibacterial agents.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Regulation of multiple dimeric states of E-cadherin by adhesion activating antibodies revealed through Cryo-EM and X-ray crystallography

Allison Maker, Madison Bolejack, Leslayann Schecterson, Brad Hammerson, Jan Abendroth, Thomas E. Edwards, Bart Staker, Peter J. Myler, Barry M. Gumbiner

Summary: This study utilizes cryo-electron microscopy (EM) and X-ray crystallography to investigate the regulation of E-cadherin adhesion on cell surface. Novel dimer conformations were observed in solution through cryo-EM, and activating antibodies were used to alter the adhesive dimer state. The structures of activating Fabs bound to E-cadherin reveal new insights into the regulation of cell adhesion.

PNAS NEXUS (2022)

暂无数据